Assyro AI

Orange Book product · Brand (NDA)

EDLUAR

ZOLPIDEM TARTRATE

Brand (NDA)NDA 021997TE ABRX VIATRIS

At a glance

Mar 13, 2009

Approved

Brand (NDA)

Application

AB

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 13, 2009

    17 yr 6 mo ago

  2. Today

  3. Patent 9597281 expires

    Listed method-of-use patent (U-674) expiration.

    Apr 06, 2027

    in 10 mo

  4. Patent 9265720 expires

    Listed method-of-use patent (U-674) expiration.

    Feb 25, 2031

    in 4 yr 9 mo

Pharmaceutical detail

Active ingredient

ZOLPIDEM TARTRATE

Strength

5MG

Dosage form

TABLET

Route

SUBLINGUAL

TE code

AB

Application

NDA 021997

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9597281Apr 06, 2027in 10 mo
U-674
9265720Feb 25, 2031in 4 yr 9 mo
U-674
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.